Joseph Jimenez

Novartis Pharma Schweiz AG engages in the marketing and distribution of pharmaceutical, chemical, and medical products of the Novartis group. Its products are used in the treatment of diseases in the areas of neurology, immunology, dermatology, ophthalmology, cardiology, and oncology. The company was founded on December 10, 1986 and is headquartered in Rotkreuz, Switzerland.

Pinnacle Foods Group LLC operates as a producer, marketer, and distributor of shelf stable and frozen food products. Its products are sold through supermarkets, grocery wholesalers and distributors, mass merchandisers, convenience stores, warehouse clubs and military channels. The company was founded on June 19, 1998 and is headquartered in Parsippany, NJ.

Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ.

Heinz North America Consumer Products manufactures snack foods. Its products include mustard and barbecue and pasta sauces that are sold under the Heinz 57, Jack Daniels, Classico pasta sauces, and Lea & Perrins Worcestershire brands. The company is located in Pittsburgh, PA.

Speedel Holding operates as a holding company with interests in pharmaceutical manufacturing. The company was founded on July 19, 2000 and is headquartered in Basel, Switzerland.

Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. It researches on Renin Inhibitors and also develops an Endothelin Receptor Anatagonist. The company also operates in the U.S. and Japan. It was founded in 1998 and is headquartered in Basel, Switzerland.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Pinnacle Foods Finance LLC produces and markets food products. The company was founded on March 5, 2007 and is headquartered in Parsippany, NJ.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Part of GSK Plc, Novartis Consumer Health, Inc. manufactures and supplies pharmaceutical products. The private company is based in Lincoln, NE.

Part of Blackstone, Inc., The Blackstone Group enables leading energy companies to build enterprises at scale that can deliver clean, reliable and affordable energy to help meet needs. The private company is based in Beijing, China. The Chinese company invests in companies shaping the future, helping emerging leaders become champions through the power of the Blackstone platform.

uBiome, Inc. operates as a biotechnology company. It provides information and tools to explore the populations of bacteria that live on and inside human body. The firm sends customers a kit to collect a tiny stool, mouth, nose, genitals and skin sample and the samples, coupled with a detailed questionnaire, let uBiome's lab compare results with a stockpile of other information from a user database. The company was founded by Zachary Apte and Jessica Richman in November 2012 and is headquartered in San Francisco, CA.

Aditum Bio Fund 1 LP specializes in acquiring and developing pharmaceutical assets. The company is headquartered in San Mateo, CA.

Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA.

Aditum Bio Management Co. LLC is a biotech venture capital company based in Oakland, CA. Aditum Bio is committed to improving public health by accelerating research and development in disease areas with both large and more targeted patient populations. The private company focuses on basic mechanisms of disease, in-license promising drug candidates, and spin-out individual companies dedicated to bringing each candidate through phase II clinical trials. In partnership with Trialspark, Aditum Bio uses data, software, and technology to help bring innovative medicines through the clinical trial phase more quickly and with lower costs than traditional pharmaceutical companies. The company was founded by Paul Sekhri, Joseph Jimenez, and Mark Fishman.

Century Therapeutics, Inc. operates as a biotechnology company. It develops transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need. The company has created a allogeneic cell therapy platform that includes induced pluripotent stem cells, or iPSCs, differentiation know-how to generate immune effector cells from iPSCs, or iPSC-derived cells, clustered regularly interspaced short palindromic repeats, or CRISPR, mediated precision gene editing that allows it to incorporate multiple transgenes and remove target genes intended to optimize cell product performance, sophisticated protein engineering capabilities to develop proprietary next generation chimeric antigen receptors, or CARs, its proprietary Allo-EvasionTM technology intended to prevent rejection of its cell products by the host immune system, and cutting edge manufacturing capabilities intended to minimize product development and supply risk. Century Therapeutics was founded on March 5th, 2018 and is headquartered by Philadelphia, PA.

Part of Eli Lilly & Co., Versanis Bio, Inc. is a clinical-stage biopharmaceutical company. The private company is based in New York, NY. The company was founded by Lloyd Klickstein. Mark E. Pruzanski has been the CEO of the company since 2021. Versanis Bio was acquired by Eli Lilly & Co. on August 14, 2023 for $1,925 million.

Via Nova Therapeutics, Inc. is a company that aims to discover and develop safe and effective therapies for viral diseases with inadequate treatments. The company is based in Oakland, CA. Via Nova's pipeline includes four programs targeting influenza, human rhinovirus, polyomavirus, and adenovirus. The company is committed to advancing this initial pipeline with additional discovery efforts to follow. Via Nova believes that the recent expansion of point-of-care testing and telemedicine driven by the COVID-19 pandemic will transform the diagnostic landscape, allowing early recognition of all the important respiratory viruses. The company was founded in August 2021 and has in-licensed antiviral programs from RTIs. The CEO of the company is Donald Emil Ganem.

Teres Bio, Inc. operates as a clinical stage life sciences company. It translates discoveries in inflammatory pathways into novel, topical therapies for atopic dermatitis and plaque psoriasis skin diseases. The company is headquartered in Oakland, CA.

Anteris Bio, Inc. develops therapies for the treatment of renal disease. The company is based in Oakland, CA. The CEO of the company is Ilan Zipkin.